Researchers have modified T cell receptors, the antenna-like structures of T cells, to make them more potent against cancer. This modification is the precondition for the immune system to destroy cancer cells. The researchers developed a mouse with a whole repertoire of human T cell receptors with the aim of utilizing them in the future for targeted immunotherapy in patients.